Publications and communications of David Waltregny

Goffioul, L., ZJUKOVITSJ, D., Moïse, M., Waltregny, D., & Detry, O. (2023). Repair of parastomal hernia after Bricker procedure: retrospective consecutive experience of a tertiary center. Hernia. doi:10.1007/s10029-023-02940-7

Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366

Khuc, C., Sempels, M., Bonnet, Q., & Waltregny, D. (July 2022). Carcinome rénal se présentant sous forme d’un abcès rénal. Revue Médicale de Liège, 77 (7-8), 426 - 429.

Goffioul, L., Moïse, M., Waltregny, D., & Detry, O. (05 May 2022). Surgical repair of parastomal hernia after Bricker procedure: consecutive experience of a tertiary center [Paper presentation]. Belgian Surgical Week 2022, Ostende, Belgium.

GOFFIOUL, L., Bonnet, P., Waltregny, D., & Detry, O. (12 December 2021). Parastomal Hernia after Radical Cystectomy with Ileal Conduit Diversion: A Narative Review. Acta Chirurgica Belgica, 121 (6), 373-379. doi:10.1080/00015458.2021.1987617

SEMPELS, M., Ben Chehida, M. A., MEUNIER, P., & WALTREGNY, D. (July 2021). Open and Laparoscopic Partial Nephrectomy: Comparison and Validation of Preoperative Scoring Systems, Including PADUA, RENAL, ABC Nephrometric Scores and Perinephric Fat Evaluation with Mayo Adhesive Probability Score. Research and Reports in Urology, 19 (13), 509-517. doi:10.2147/RRU.S293864

Colassin, A., Denis, C., HERMESSE, J., WALTREGNY, D., & SAUTOIS, B. (May 2021). Prise en charge d'un cancer de la prostate métastatique au diagnostic. Revue Médicale de Liège, 76 (5-6), 496-501.

Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., Spotbeen, X., Bagadi, M., WALTREGNY, D., Moldovan, M., Dehairs, J., Vanderhoydonc, F., Bloch, K., Das, R., Stahl, J., Kench, J. G., Gevaert, T., Derua, R., Waelkens, E., ... Swinnen, J. V. (2021). Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. Cancer Research, 81 (19), 4981-4993. doi:10.1158/0008-5472.CAN-20-3863

Sohngen, F., SEMPELS, M., & WALTREGNY, D. (December 2020). Comment je traite… Une sténose de l’urètre masculine. Revue Médicale de Liège, 75 (12), 822-824.

VALDES SOCIN, H. G., & WALTREGNY, D. (July 2020). Covid-19 et TMPRSS2: aspects endocriniens et perspectives thérapeutiques. Urologic, 16 (2), 6-8.

ANDRIANNE, C., DEWANDRE, M., El Hachem, G., Burkhard, F., Andrianne, R., & Waltregny, D. (2020). Métastase de carcinome lobulaire mammaire sur un patch iléal d’entérocystoplastie. Revue Médicale de Liège, 75 (7-8), 537-540.

BONNET, Q., COPPENS, L., DELVIGNE, A., & WALTREGNY, D. (2020). Impact précoce de la sclérothérapie antégrade de varicocèle gauche clinique sur le spermogramme. Progres en Urologie - FMC, 30, 281-287. doi:10.1016/j.purol.2020.02.010

de Leval, J., & Waltregny, D. (2020). Évaluation des complications et échecs nécessitant réintervention chirurgicale après implantation initiale d’une bandelette transobturatrice pour incontinence urinaire d’effort chez la femme : résultats d’une série rétrospective avec suivi médian de 10 an. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 30 (13), 755-756. doi:10.1016/j.purol.2020.07.106

Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4

Hermanns, T., Savio, A. J., Olkhov-Mitsel, E., Mari, A., Wettstein, M. S., Saba, K., Bhindi, B., Kuk, C., Poyet, C., Wild, P. J., Noon, A., Bashir, S., Juvet, T., Rendon, R. A., Waltregny, D., van der Kwast, T., Finelli, A., Kulkarni, G. S., Fleshner, N. E., ... Zlotta, A. R. (2020). A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. Urologic Oncology, 38 (6), 603.e1-603.e7. doi:10.1016/j.urolonc.2020.01.007

Sohngen, F., Sempels, M., Bonnet, P., Meunier, P., & Waltregny, D. (2020). Comment j’explore… les sténoses urétrales : intérêt de l’urétrocystographie. Revue Médicale de Liège, 75 (11), 748-753.

TRIFFAUX, F., Waltregny, D., & Nechifor Vlad, A. (2020). L’évolution des traitements de l’adénome prostatique au cours des 10 dernières années. Revue Médicale de Liège, 75 (5-6), 440-444.

DEWANDRE, M., Waltregny, D., de Leval, J., & LERUTH, J. (October 2019). Urodynamic evaluation of patients cured of their post-radical prostatectomy stress urinary incontinence following transobturator male sling implantation [Évaluation urodynamique de patients guéris d'incontinence urinaire d'effort post-prostatectomie radicale après implantation d'une bandelette sous-urétrale transobturatrice]. Progrès en Urologie, 29, 1041-1046. doi:10.1016/j.purol.2019.09.001

Clery, R., Grande, P., Seisen, T., Gobert, A., Duquesne, I., Villers, A., Olivier, J., Bernhard, J.-C., Robert, G., Beauval, J. B., Prudhomme, T., Bruyère, F., Lainé-Caroff, P., Waltregny, D., Guillonneau, B., Panarello, D., Ruffion, A., De Bayser, H., de La Taille, A., & Roupret, M. (2019). Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study. World Journal of Urology, 37 (8), 1491-1498. doi:10.1007/s00345-019-02683-0

Sempels, M., Bonnet, P., & Waltregny, D. (2019). Comment j'explore... Evaluation urologique des candidats à une transplantation rénale: Recommandations pour la pratique. Revue Médicale de Liège, 74 (3), 152-158.

Grégoire, C., Bragard, I., Nicolas, H., Delevallez, F., Merckaert, I., Razavi, D., Waltregny, D., Faymonville, M.-E., & VANHAUDENHUYSE, A. (13 November 2018). Efficacy of a hypnosis-based intervention to improve well-being for prostate and breast cancer patients [Paper presentation]. Journée doctorale en santé publique, Liège, Belgium.

Grégoire, C., FAYMONVILLE, M.-E., Bragard, I., Charland-Verville, V., Delevallez, F., Merckaert, I., Razavi, D., Gillet, A., Lewis, F., WALTREGNY, D., Nicolas, H., & VANHAUDENHUYSE, A. (22 August 2018). 3. Efficacy of a hypnosis-based intervention to improve well-being during cancer: the differences between prostate and breast cancer patients [Paper presentation]. XXI World Congress of Medical and Clinical Hypnosis, Montréal, Canada.

Grégoire, C., Nicolas, H., Bragard, I., Delevallez, F., Merckaert, I., Razavi, D., Waltregny, D., Faymonville, M.-E., & VANHAUDENHUYSE, A. (June 2018). Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients. BMC Cancer, 18 (677). doi:10.1186/s12885-018-4607-z

Peyronnet, B., O'Connor, E., Khavari, R., Capon, G., Manunta, A., Allue, M., Hascoet, J., Nitti, V. W., Game, X., Gilleran, J., Castro-Sader, L., Cornu, J.-N., Waltregny, D., Ahyai, S., Chung, E., Elliott, D. S., Fournier, G., & Brucker, B. M. (2018). AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourology and Urodynamics. doi:10.1002/nau.23833

DORMAL, M., ANDRIANNE, R., SEMPELS, M., & WALTREGNY, D. (October 2017). Implantation précoce d'une prothèse pénienne comme traitement optimal du priapisme réfractaire à bas débit. Revue Médicale de Liège, 72 (10), 454-456.

Ben Chehida, M. A., Andrianne, R., & Waltregny, D. (15 February 2017). Cowper's Syringocele Revealed by Post-micturition Dribbling in an Adult. Journal of Genital System and Disorders, 6 (2). doi:10.4172/2325-9728.1000170

Fusco, F., Abdel-Fattah, M., Chapple, C. R., Creta, M., La Falce, S., Waltregny, D., & Novara, G. (2017). Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. European Urology, 72 (4), 567-591. doi:10.1016/j.eururo.2017.04.026

Gomez, F. D., Thomas, A., Sempels, M., Nechifor, V., Hubert, C., Leruth, J., & Waltregny, D. (2017). Outcomes Following First-line Endourologic Management of Ureteroenteric Anastomotic Strictures After Urinary Diversion: A Single-center Study. Urology, 102, 38-42. doi:10.1016/j.urology.2016.10.009

PIRAPREZ, M., QUINONEZ, K., SEMPELS, M., Waltregny, D., Krzesinski, J.-M., & Jouret, F. (2017). Obstruction urinaire basse : Attention à la levée d'obstacle ! Revue Médicale de Liège, 72 (12), 529-533.

Lavergne, O., Bonnet, Q., Thomas, A., & Waltregny, D. (2016). COMMENT JE TRAITE ... une colique néphrétique. Revue Médicale de Liège, 71 (5), 220-6.

Lavergne, O., Thomas, A., Andrianne, R., Waltregny, D., & Coppens, L. (2016). Priapisme a haut debit d'origine traumatique : mise au point diagnostique, apport de l'echographie et recommandations. Revue Médicale de Liège, 71 (11), 513-516.

Waltregny, D. (2016). Mode of Delivery: A Modifiable Risk Factor for Subsequent Stress Urinary Incontinence? European Urology, 70 (1), 159-60. doi:10.1016/j.eururo.2016.03.006

WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021

Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003

de Leval, J., Leruth, J., & Waltregny, D. (2015). Le TOM-Sling(R), un nouveau sling transobturateur de dedans en dehors pour le traitement de l'incontinence urinaire d'effort post-prostatectomie radicale : procedure d'implantation. Progrès en Urologie, 25 (13), 865.

Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège [Paper presentation]. Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

GADISSEUR, R., Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., & CAVALIER, E. (September 2014). Epidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

KEPPENNE, V., Sanjurjo, S., Bottin, C., & Waltregny, D. (2014). Le catheterisme intermittent, methode de choix dans la prise en charge des dysfonctionnements neurologiques vesico-sphincteriens : notre experience a propos de 154 patients atteints d'une sclerose en plaques. Progrès en Urologie, 24 (13), 842-3.

Lee, R. K., Mottrie, A., Payne, C. K., & Waltregny, D. (2014). A Review of the Current Status of Laparoscopic and Robot-assisted Sacrocolpopexy for Pelvic Organ Prolapse. European Urology, 65 (6), 1128-1137. doi:10.1016/j.eururo.2013.12.064

LERUTH, J., FILLET, M., & Waltregny, D. (2013). Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing. International Urogynecology Journal, 24 (3), 485-491. doi:10.1007/s00192-012-1888-7

Waltregny, D. (2013). TVT-O: a new gold standard surgical treatment of female stress urinary incontinence? European Urology, 63 (5), 879-880. doi:10.1016/j.eururo.2013.01.017

Waltregny, D., & de Leval, J. (07 October 2012). New surgical technique for treatment of stress urinary incontinence TVT-ABBREVO: From development to clinical experience. Surgical Technology International, XXII (pii), 22/23.

LERUTH, J., Waltregny, D., & de Leval, J. (2012). The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center Prospective Study. European Urology, 61 (3), 608-615. doi:10.1016/j.eururo.2011.10.036

WITHOFS, N., SIGNOLLE, N., NZARAMBA, E., THONON, D., LEONARD, M., AERTS, J., WALTREGNY, D., CATALDO, D., GAMBHIR, S., & HUSTINX, R. (2012). (18F)FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas : correlation with histopathology. Journal of Nuclear Medicine, 53 (SUPPL), 1647.

WALTREGNY, D. (30 April 2011). Les traitements chirurgicaux de l'incontinence urinaire d'effort féminine: Où en sommes-nous en 2011? Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 166 (3-4), 157-168.

Bonnet, P., Hinoul, P., Krofta, L., Waltregny, D., & de Leval, J. (2011). An anatomic comparison of the original versus a modified inside-out transobturator procedure. International Urogynecology Journal. doi:10.1007/s00192-011-1415-2

RATY, L., FAILLA, V., Andrianne, R., FILLET, M., Waltregny, D., & NIKKELS, A. (05 January 2011). Chronic Idiopathic Penile Edema: Three Cases and a Review of the Literature. Open Dermatology Journal, 5, 1-5. doi:10.2174/1874372201105010001

De Leval, J., Thomas, A., & Waltregny, D. (2011). The original versus a modified inside-out transobturator procedure: 1-year results of a prospective randomized trial. International Urogynecology Journal, 22 (2), 145-156. doi:10.1007/s00192-010-1264-4

Kischel, P., Waltregny, D., Greffe, Y., Mazzucchelli, G., De Pauw, E., de Leval, L., & Castronovo, V. (2011). Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma. Proteome Science, 9 (1), 63. doi:10.1186/1477-5956-9-63

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5

Fleron, M., Greffe, Y., Musmeci, D., Massart, A.-C., Hennequière, V., Mazzucchelli, G., Waltregny, D., De Pauw-Gillet, M.-C., De Pauw, E., Castronovo, V., & Turtoi, A. (10 September 2010). Novel post-digest isotope coded protein labeling method for phospho- and glycoproteome analysis. Journal of Proteomics, 73 (10), 1986-2005. doi:10.1016/j.jprot.2010.06.003

Valdes Socin, H. G., Waltregny, D., & Beckers, A. (September 2010). Résistance au traitement par GnRH agonistes dans le cancer de la prostate métastatique. Annales d'Endocrinologie, 71 (5), 396.

Valdes Socin, H. G., Waltregny, D., & Beckers, A. (2010). Complete Resistance to Gonadotropin Hormone Releasing Hormone (Gn-RH) Agonist Therapy for Metastatic Prostate Cancer. In European Neuroendocrine Association - Liège, 22-25 septembre 2010.

Castronovo, V., Waltregny, D., & Kischel, P. (07 July 2010). An in-vitro method for screening accessible biological markers in pathologic tissues.

Fillet, M., & Waltregny, D. (June 2010). Fistule recto-vésicale : une complication exceptionnelle après promontofixation laparoscopique [Paper presentation]. 33ème congrès de la Société Francophone Internationale d’Urodynamique et de Pelvi-Périnéologie, Lille, France.

de Leval, L., Lim, G. S. D., Waltregny, D., & Oliva, E. (2010). Diverse phenotypic profile of uterine tumors resembling ovarian sex cord tumors: an immunohistochemical study of 12 cases. American Journal of Surgical Pathology, 34 (12), 1749-61. doi:10.1097/PAS.0b013e3181f8120c

Fillet, M., Keppenne, V., Vandeberg, C., De Leval, J., & Waltregny, D. (2010). Erosions vaginales en promontofixation laparoscopique. Facteurs favorisants ? [Paper presentation]. 33ème congrès de la Société Francophone Internationale d’Urodynamique et de Pelvi-Périnéologie, Lille, France.

Hinoul, P., Bonnet, P., De Roover, C., Gomez, F., Waltregny, D., & de Leval, J. (2010). An anatomic comparison of the traditional TVT-O versus a modified TVT-O procedure. Gynecological Surgery, 7 (Suppl 1), 121.

Kischel, P., Waltregny, D., Dumont, B., Turtoi, A., Greffe, Y., Kirsch, S., De Pauw, E., & Castronovo, V. (2010). Versican overexpression in human breast cancer lesions: Known and new isoforms for stromal tumor targeting. International Journal of Cancer, 126 (3), 640-50. doi:10.1002/ijc.24812

Novara, G., Artibani, W., Barber, M. D., Chapple, C. R., Costantini, E., Ficarra, V., Hilton, P., Nilsson, C. G., & Waltregny, D. (2010). Updated Systematic Review and Meta-Analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. European Urology. doi:10.1016/j.eururo.2010.04.022

Renard, I., Joniau, S., van Cleynenbreugel, B., Collette, C., Naome, C., Vlassenbroeck, I., Nicolas, H., de Leval, J., Straub, J., Van Criekinge, W., Hamida, W., Hellel, M., Thomas, A., De Leval, L., Bierau, K., & Waltregny, D. (2010). Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples. European Urology. doi:10.1016/j.eururo.2009.07.041

Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Van Veldhoven, P. P., Waltregny, D., Daniels, V. W., Machiels, J., Vanderhoydonc, F., Smans, K., Waelkens, E., Verhoeven, G., & Swinnen, J. V. (2010). De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Research, 70 (20), 8117-26. doi:10.1158/0008-5472.CAN-09-3871

Thomas, A., Waltregny, D., & de Leval, J. (2010). One year results of a prospective randomized trial comparing the original inside-out transobturator (TVT-O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence. Neurourology and Urodynamics, 29, 1023-1025.

THOMAS, A., Waltregny, D., & de Leval, J. (2010). One year results of a prospective randomized trial comparing the original inside-out transobturator (TVT-O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence. Neurourology and Urodynamics, 29, 1023-1025.

Waltregny, D. (2010). Syndromes douloureux pelviens : La prostate serait-elle le tendon d’Achille de l’homme mûr ? Andrologic, 6 (3), 81.

Waltregny, D., LERUTH, J., & de Leval, J. (2010). The inside-out transobturator sling for the surgical treatment of post-radical prostatectomy urinary incontinence: Interim results of a prospective, observational study after a 2-year minimum follow-up. Neurourology and Urodynamics, 29, 921-922.

Waltregny, D., Leruth, J., & de Leval, J. (2010). The inside-out transobturator sling for the surgical treatment of post-radical prostatectomy urinary incontinence: Interim results of a prospective, observational study after a 2-year minimum follow-up. Neurourology and Urodynamics, 29, 921-922.

Waltregny, D., THOMAS, A., & de Leval, J. (2010). Vers une approche moins invasive du traitement chirurgical de l'incontinence urinaire féminine: la voie transoburatrice de dedans en dehors (TVT-O). Andrologic, 6 (5), 1-4.

Waltregny, D., Thomas, A., & de Leval, J. (2010). Vers une approche moins invasive de la voie transoburatrice de dedans en dehors (TVT-O) pour le traitement de l’incontinence urinaire féminine: dissection réduite et bandelette plus courte. Andrologic, 6.

Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (October 2009). Le ciblage therapeutique: vers une guerre propre et efficace contre le cancer [Paper presentation]. Journée Synthèse 2009 CHU La recherche translationnelle au CHU de Liège, Liège, Belgium.

Waltregny, D., Joniau, S., Bierau, K., & Renard, I. (October 2009). Détecter le cancer de la vessie à partir d’échantillons d’urine [Paper presentation]. Journée Synthèse 2009 CHU La recherche translationnelle au CHU de Liège, Liège, Belgium.

Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760

Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (2009). Le ciblage thérapeutique : vers une guerre propre et efficace contre le cancer. Revue Médicale de Liège, 64, 20-23.

Renard, I., Joniau, S., van Cleynenbreugel, B., Collette, C., Naômé, C., Vlassenbroeck, I., Nicolas, H., de Leval, J., Straub, J., Van Criekinge, W., Hamida, W., Hellel, M., Thomas, A., de Leval, L., Bierau, K., & Waltregny, D. (2009). Identification and validation of the methylated TWIST1 and NID2 genes through Real time Methylation-Specific PCR (MSP) assay for the non-invasive detection of bladder cancer in urine samples [Poster presentation]. 6th Early Detection Research Network (EDRN) Scientific Workshop, Bethesda, MD, United States.

Thomas, A., Renard, I., & Waltregny, D. (2009). Détection du cancer de la vessie à partir d'échantillons d'urine. Revue Médicale de Liège, 64, 9-14.

Waltregny, D., & De Leval, J. (2009). The TVT-obturator surgical procedure for the treatment of female stress urinary incontinence: a clinical update. International Urogynecology Journal, 20 (3), 337-48. doi:10.1007/s00192-008-0753-1

Waltregny, D., Leruth, J., & de Leval, J. (2009). The inside-out transobturator sling for the surgical treatment of post-radical prostatectomy urinary incontinence: Interim results of a prospective, observational study after a 1-year minimum follow-up. Neurourology and Urodynamics, 28 (7), 687-688.

Waltregny, D., Gaspar, Y., Hamida, W., Bonnet, P., & de Leval, J. (February 2008). TVT-O for the Treatment of Female Stress Urinary Incontinence: Results of a Prospective Study after a 3-Year Minimum Follow-Up. European Urology, 53 (2), 401-8. doi:10.1016/j.eururo.2007.08.021

Conrotto, P., Roesli, C., Rybak, J., Kischel, P., Waltregny, D., Neri, D., & Castronovo, V. (2008). Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. International Journal of Cancer, 123 (12), 2856-2864. doi:10.1002/ijc.23861

Conrotto, P., Roesli, C., Rybak, J., Kischel, P., Waltregny, D., Neri, D., & Castronovo, V. (2008). Identification and characterization of new blood-accessible colorectal cancer biomarkers [Paper presentation]. 7th annual world congress of Human Proteome Organization (HUPO), Amsterdam, Netherlands.

de Leval, J., & Waltregny, D. (2008). The inside-out transobturator sling for the treatment of male urinary incontinence. Journal of Urology, 179 (4), 123. doi:10.1016/S0022-5347(08)60352-3

de Leval, J., & Waltregny, D. (2008). The inside-out trans-obturator sling: a novel surgical technique for the treatment of male urinary incontinence. European Urology, 54 (5), 1051-65. doi:10.1016/j.eururo.2007.11.025

Kischel, P., Greffe, Y., Waltregny, D., Chrétien, N., Mazzucchelli, G., De Pauw, E., de Leval, L., & Castronovo, V. (2008). Contribution of glycoproteomics in the search for accessible biomarkers in human lymphoma [Paper presentation]. FNRS Contact Group Proteomics (GCProt) 4th annual meeting: Chromatin Modifications and Protein Glycosylation, Louvain-la-Neuve, Belgium.

Waltregny, D. (2008). Editorial comment on: complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices. European Urology, 53 (2), 308-9. doi:10.1016/j.eururo.2007.10.074

Waltregny, D., Leruth, J., & de Leval, J. (2008). The Inside-Out Transobturator Sling for the surgical treatment of post-radical prostatectomy urinary incontinence: Results of a prospective study after a minimum of 6 months. European Urology Supplements, 8 (4), 336 (A862. doi:10.1016/S1569-9056(09)60848-4

Mottet, D., Bellahcene, A., Pirotte, S., Waltregny, D., Deroanne, C., Lamour, V., Lidereau, R., & Castronovo, V. (07 December 2007). Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circulation Research, 101 (12), 1237-1246. doi:10.1161/CIRCRESAHA.107.149377

Kischel, P., Waltregny, D., & Castronovo, V. (December 2007). Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies. Expert Review of Proteomics, 4 (6), 727-739. doi:10.1586/14789450.4.6.727

Ahuja, N., Schwer, B., Carobbio, S., Waltregny, D., North, B. J., Castronovo, V., Maechler, P., & Verdin, E. (16 November 2007). Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. Journal of Biological Chemistry, 282 (46). doi:10.1074/jbc.M705488200

Dhaese, S., Jonckheere, V., Goethals, M., Waltregny, D., Vandekerckhove, J., Ampe, C., & Van Troys, M. (16 October 2007). Functional and profiling studies prove that prostate cancer upregulated neuroblastoma thymosin beta is the true human homologue of rat thymosin beta 15. FEBS Letters, 581 (25), 4809-4815. doi:10.1016/j.febslet.2007.09.003

Glenisson, W., Castronovo, V., & Waltregny, D. (October 2007). Histone deacetylase 4 is required for TGF beta 1-induced myofibroblastic differentiation. BBA Molecular Cell Research, 1773 (10), 1572-1582. doi:10.1016/j.bbamcr.2007.05.016

Castronovo, V., Kischel, P., Guillonneau, F., de Leval, L., Defechereux, T., De Pauw, E., Neri, D., & Waltregny, D. (April 2007). Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method. Proteomics, 7 (8), 1188-1196. doi:10.1002/pmic.200600888

Stabile, H., Mitola, S., Moroni, E., Belleri, M., Nicoli, S., Coltrini, D., Peri, F., Pessi, A., Orsatti, L., Talamo, F., Castronovo, V., Waltregny, D., Cotelli, F., Ribatti, D., & Presta, M. (01 March 2007). Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood, 109 (5), 1834-1840. doi:10.1182/blood-2006-06-032276

Waltregny, D. (2007). Characterization of the epithelium and stroma of the benign and malignant prostate: Molecular, morphological and functional studies and diagnostic applications [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/36199

de Leval, J., Bonnet, P., Hamida, W., Maréchal, C., & Waltregny, D. (2007). Cure d’incontinence urinaire masculine par prothèse sous-bulbaire trans-obturatrice in-out [Paper presentation]. 101ème congrès de l’Association Française d’Urologie, Paris, France.

de Leval, J., Bonnet, P., & Waltregny, D. (2007). Actualités therapeutiques en urologie. Le TVT-O, nouvelle technique mini-invasive pour le traitement de l'incontinence urinaire d'effort féminine, développements et expérience clinique. Revue Médicale de Liège, 62 Spec No, 86-94.

Glénisson, W., Waltregny, D., & Castronovo, V. (2007). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Spring meeting of the Belgian Society for Cell and Developmental Biology, Liège, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2007). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Pignon, J.-C., Delacroix, L., Nolens, G., Waltregny, D., & Winkler, R. (2007). Regulation by androgens of the expression of the EGF receptor family members in prostate cancer cells [Paper presentation]. Spring meeting of the Belgian Society for Cell and Developmental Biology, Liège, Belgium.

Renard, I., Kelly, J., Collette, C., Naômé, C., Nicolas, H., Zwarthoff, E., Straub, J., Van Criekinge, W., Suraparaju, L., Bierau, K., & Waltregny, D. (2007). Feasibility of a urine-based DNA methylation assay for early detection of bladder cancer [Poster presentation]. 2nd AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development: Maximizing Opportunities for Individualized TreatmentA, Atlanta, GA, United States.

Vener, T. I., Derecho, C., Varde, S., Mazumder, A., Groteclaes, M., Bierau, K., Louwagie, J., Bigley, J., de Leval, L., Gaspar, Y., Coppens, L., de Leval, J., & Waltregny, D. (2007). Development of urine-based DNA methylation assay for prostate cancer screening [Poster presentation]. 98th annual meeting of the American Association for Cancer Research, Los Angeles, CA, United States.

Waltregny, D., Gaspar, Y., Hamida, W., Reul, O., Bonnet, P., & de Leval, J. (2007). TVT-O pour le traitement de l'incontinence urinaire d'effort féminine : résultats d'une étude prospective avec suivi minimal de 3 ans [Paper presentation]. 101ème congrès de l’Association Française d’Urologie, Paris, France.

Wedel, T., Waltregny, D., Bogers, J. P., & Vanderwinden, J.-M. (2007). Alpha-smooth muscle actin immunoreactivity in the human ileum: playing foul play? [Paper presentation]. 19th Belgian Week of Gastroenterology, Ostende, Belgium.

Castronovo, V., Waltregny, D., Kischel, P., Roesli, C., Elia, G., Rybak, J. N., & Neri, D. (November 2006). A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Molecular and Cellular Proteomics, 5 (11), 2083-2091. doi:10.1074/mcp.M600164-MCP200

Dassesse, T., de Leval, X., de Leval, L., Pirotte, B., Castronovo, V., & Waltregny, D. (November 2006). Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. European Urology, 50 (5), 1021-31, discussion 1031. doi:10.1016/j.eururo.2006.01.036

de Leval, X., Dassesse, T., Dogné, J.-M., Waltregny, D., Bellahcene, A., Benoit, V., Pirotte, B., & Castronovo, V. (September 2006). Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents. Journal of Pharmacology and Experimental Therapeutics, 318 (3), 1057-1067. doi:10.1124/jpet.106.101188

Wedel, T., Van Eys, G., Waltregny, D., Glenisson, W., Castronovo, V., & Vanderwinden, J.-M. (July 2006). Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterology and Motility, 18 (7), 526-538. doi:10.1111/j.1365-2982.2006.00781.x

Waltregny, D., Reul, O., Mathantu, B., Gaspar, Y., Bonnet, P., & De Leval, J. (June 2006). Inside out transobturator vaginal tape for the treatment of female stress urinary incontinence: Interim results of a prospective study after a 1-year minimum followup. Journal of Urology, 175 (6), 2191-2195. doi:10.1016/S0022-5347(06)00277-1

Nickers, P., Albert, A., Waltregny, D., & Deneufbourg, J.-M. (01 May 2006). Prognostic value of PSA nadir < or =4 ng/ml within 4 months of high-dose radiotherapy for locally advanced prostate cancer. International Journal of Radiation, Oncology, Biology, Physics, 65 (1), 73-77. doi:10.1016/j.ijrobp.2005.11.026

de Leval, L., Waltregny, D., Boniver, J., Young, R., Castronovo, V., & Oliva, E. (March 2006). Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. American Journal of Surgical Pathology, 30 (3), 319-327. doi:10.1097/01.pas.0000188029.63706.31

Verdin, E. M., Waltregny, D., & Castronovo, V. (02 February 2006). Methods of treating smooth muscle cell disorders.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (February 2006). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. International Journal of Cancer, 118 (4), 850-856. doi:10.1002/ijc.21442

Waltregny, D., & Castronovo, V. (2006). The biology of HDAC8. New Jersey, United States: The Humana Press Inc.

Mottet, D., Bellahcene, A., Waltregny, D., Lidereau, R., & Castronovo, V. (20 January 2006). Histone deacetylase HDAC7 as a key regulator of the angiogenic process [Poster presentation]. Annual meeting of the European STROMA consortium, Paris, France.

Castronovo, V., Kischel, P., Guillonneau, F., de Leval, L., Deféchereux, T., De Pauw, E., Neri, D., & Waltregny, D. (2006). Identification of accessible proteins expressed in human breast cancer [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Dassesse, T., de Leval, X., Dogné, J.-M., Waltregny, D., Bellahcene, A., Pirotte, B., & Castronovo, V. (2006). Evaluation of original dual thromboxane A2 modulators as anti-angiogenic agents [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

de Leval, L., Waltregny, D., Dupuis, L.-M., Boniver, J., & Oliva, E. (January 2006). Uterine tumors resembling ovarian sex-cord tumors: A study of 14 cases showing a diverse phenotypic profile. Laboratory Investigation, 86 (Suppl. 1), 176.

de Leval, L., Waltregny, D., Dupuis, L.-M., Boniver, J., & Oliva, E. (January 2006). Uterine tumors resembling ovarian sex-cord tumors: A study of 14 cases showing a diverse phenotypic profile. Modern Pathology, 19 (Suppl. 1), 176.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. 8th meeting of the Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Bruxelles, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Etude du rôle des histones déacétylases dans la différenciation myofibroblastique [Paper presentation]. Séminaire Télévie, Louvain-la-Neuve, Belgium.

Glénisson, W., Waltregny, D., Tran, S. L., North, B., Verdin, E., & Castronovo, V. (2006). Histone deacetylase HDAC8 associates with smooth muscle alpha–actin and is essential for smooth muscle cell contractility [Paper presentation]. 10th Bioforum, Liège, Belgium.

Mottet, D., Bellahcene, A., Deroanne, C., Lamour, V., Waltregny, D., & Castronovo, V. (2006). Histone deacetylase 7 is involved in the control of angiogenesis by regulating platelet-derived growth factor-β [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Pignon, J.-C., Delacroix, L., Nolens, G., Waltregny, D., & Winkler, R. (2006). Androgens regulation of the ERBB1 and ERBB2 oncogene expression in human prostate cancer cells [Poster presentation]. Annual meeting of the Belgian Association for Cancer Research, Liège, Belgium.

Pignon, J.-C., Delacroix, L., Waltregny, D., & Winkler, R. (2006). Regulation by androgens of EGF receptor family members in prostate cancer cells. Proceedings of the American Association for Cancer Research.

Pignon, J.-C., Delacroix, L., Waltregny, D., & Winkler, R. (2006). Androgens regulation of the ERBB1 and ERBB2 oncogene expression in human prostate cancer cells. Acta Clinica Belgica, 61 (2, MAR-APR), 95-95.

Timmermans, L., Kischel, P., Beckers, A., Vanderhoydonc, F., Organe, S., Brusselmans, K., Waltregny, D., Castronovo, V., Verhoeven, G., & Swinnen, J. (2006). Role of tumor-associated lipogenesis in the formation and composition of membrane microdomains [Paper presentation]. 10th meeting of the Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Bruxelles, Belgium.

De Leval, J., Bonnet, P., Waltregny, D., Reul, O., & Gaspar, Y. (December 2005). Re: Transobturator surgery of urinary incontinence in women by means of transobturator procedures: Outside in or inside out? Comparative anatomical study. By Spinosa J.P., Dubuis P.Y., Riederer B. Prog. Urol., 2005, 15 (4):700-706. Progrès en Urologie, 15 (6), 1161-1162.

Waltregny, D. (June 2005). Examination of the non-palpable cryptorchid testis [Paper presentation]. Annual meeting of the Belgian Association of Urology, Gent, Belgium.

Waltregny, D., Keppenne, V., Reul, O., Bonnet, P., & de Leval, J. (16 March 2005). Inside-out transobturator vaginal tape (TVT-O): One-year results of a prospective study [Poster presentation]. EAU congress 2005, Istambul, Turkey.

Soubry, A., van Hengel, J., Parthoens, E., Colpaert, C., Van Marck, E., Waltregny, D., Reynolds, A. B., & van Roy, F. (March 2005). Expression and nuclear location of the transcriptional repressor kaiso is regulated by the tumor microenvironment. Cancer Research, 65 (6), 2224-2233. doi:10.1158/0008-5472.CAN-04-2020

Leruth, J., Coppens, L., Andrianne, R., Bonnet, P., Waltregny, D., & De Leval, J. (February 2005). Lipomatose pelvienne associee a une cystite glandulaire: rapport de deux cas. Progrès en Urologie, 15 (1), 81-4.

Bonnet, P., Waltregny, D., Reul, O., & de Leval, J. (2005). Transobturator vaginal tape inside out for the surgical treatment of female stress urinary incontinence: anatomical considerations. Journal of Urology, 173 (4), 1223-8. doi:10.1097/01.ju.0000148364.13525.7b

Bonnet, P., Waltregny, D., Reul, O., & de Leval, J. (2005). Le TVT transobturateur de dedans en dehors (TVT-O): Considérations anatomiques [Paper presentation]. 28ème congrès annuel de la Société Internationale Francophone d’Urodynamique et de Pelvi-Périnéologie, Nantes, France.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer [Paper presentation]. Meeting of the Paget’s foundation, Bethesda, MA, United States.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer. Journal of Bone and Mineral Research, 20 (Suppl. 2), 45.

de Leval, J., Bonnet, P., Waltregny, D., Reul, O., Gasper, Y., & Mathantu, B. (2005). Réponse à : Chirurgie de l'incontinence urinaire a l'effort feminine par voie transobturatrice: dehors dedans ou dedans dehors? etude anatomique comparative [letter to the editor]. Progrès en Urologie, 15 (6), 1161-2.

de Leval, J., & Waltregny, D. (2005). New surgical technique for treatment of stress urinary incontinence TVT-Obturator: New developments and results. Surgical Technology International, 14, 212-21.

de Leval, L., Waltregny, D., Glenisson, W., Boniver, J., Young, R., Castronovo, V., & Oliva, E. (January 2005). Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the subclassification of mesenchymal tumors of the uterus, particularly epithelioid smooth muscle tumors. Modern Pathology, 18 (Suppl. 1), 180A-181.

Glénisson, W., Waltregny, D., Tran, S. L., North, B., Verdin, E., Colige, A., & Castronovo, V. (2005). Histone deacetylase HDAC8 associates with smooth muscle alpha–actin and is essential for smooth muscle cell contractility [Paper presentation]. Spring meeting of the Belgian Society for Cell and Developmental Biology, Louvain-la-Neuve, Belgium.

Waltregny, D., Chaplet, M., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness [Paper presentation]. Gordon Research Conference on SIBLINGs, Big Sky, MT, United States.

Waltregny, D., Glenisson, W., Tran, S. L., North, B., Verdin, E., Colige, A., & Castronovo, V. (2005). Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB Journal, 19 (8), 966-968. doi:10.1096/fj.04-2303fje

Waltregny, D., Reul, O., Bonnet, P., & de Leval, J. (2005). Transobturator tape for sling procedures. AUANews, 10, 18-21.

Waltregny, D., Reul, O., Keppenne, V., Bonnet, P., & de Leval, J. (2005). Inside-out Transobturator Vaginal Tape (TVT-O): one-year results of a prospective study. European Urology Supplements, 4 (3), 16 (A53.

Wedel, T., van Eys, G., Glénisson, W., Waltregny, D., Kramer, H., & Vanderwinden, J.-M. (2005). Abnormalities of smooth muscles in human GI motility disorders revealed by novel immunomarkers [Poster presentation]. Annual meeting of the Deutsche Gesellschaft Für Neurogastroenterologie und Motilität, Schloss Hohenkammer bei Freising, Germany.

Wedel, T., van Eys, G., Glénisson, W., Waltregny, D., & Vanderwinden, J.-M. (2005). Hidden focal abnormalities of smooth muscles in human GI motility disorders revealed by novel immunomarkers [Paper presentation]. 17th Belgian Week of Gastroenterology, Spa, Belgium.

Califice, S., Waltregny, D., Castronovo, V., & van den Brule, F. (December 2004). Lignées de carcinome prostatique et apoptose: état de la question. Revue Médicale de Liège, 59 (12), 704-10.

Waltregny, D., Reul, O., Bonnet, P., & de Leval, J. (25 August 2004). Inside-out transobturator vaginal tape (TVT-O): Short-term results of a prospective study [Poster presentation]. IUGA Congress, Paris, France.

Waltregny, D., de Leval, L., Glenisson, W., Ly Tran, S., North, B., Bellahcene, A., Weidle, U., & Castronovo, V. (August 2004). Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. American Journal of Pathology, 165 (2), 553-564. doi:10.1016/S0002-9440(10)63320-2

Bonnet, P., Waltregny, D., Reul, O., & de Leval, J. (March 2004). Inside-Out transobturator Approach for the surgical treatment of female stress incontinence, anatomical considérations [Poster presentation]. 19nd EAU Congress, Vienna, Austria.

de Leval, J., Bonnet, P., Reul, O., & Waltregny, D. (February 2004). Novel surgical technique for the treatment of female urinary incontinence: Transobturator vaginal tape inside-out. European Urology Supplements, 3 (2), 226.

Bonnet, P., Waltregny, D., Reul, O., & de Leval, J. (2004). Inside-out transobturator approach for the surgical treatment of female stress urinary incontinence: Anatomical considerations. European Urology Supplements, 3 (2), 80 (A310.

de Leval, J., Bonnet, P., Reul, O., & Waltregny, D. (2004). Novel surgical technique for the treatment of female stress urinary incontinence: Transobturator vaginal tape inside-out [Poster presentation]. 99th annual meeting of the American Urological Association, San Francisco, CA, United States.

Glénisson, W., de Leval, L., Tran, S. L., Jackers, P., North, B., Verdin, E., Castronovo, V., & Waltregny, D. (2004). La déacétylase d’histones HDAC8 est un nouveau marqueur de différenciation des cellules musculaires lisses [Paper presentation]. Séminaire des jeunes chercheurs Télévie, Louvain-la-Neuve, Belgium.

Glénisson, W., Tran, S. L., Castronovo, V., & Waltregny, D. (2004). HDAC8 is required for myofibroblastic differentiation induced by TGFß [Paper presentation]. 11th Euregional Oncology meeting, Aachen, Germany.

Glénisson, W., Tran, S. L., Castronovo, V., & Waltregny, D. (2004). HDAC8 is necessary for TGFß-induced myofibroblastic differenciation W. Glénisson, S.L. Tran, V. Castronovo, D. Waltregny [Paper presentation]. 8th meeting of Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Leuven, Belgium.

Reul, O., Waltregny, D., Bonnet, P., & de Leval, J. (2004). Le TVT transobturateur de dedans en dehors (TVT-O): Analyse des résultats après un suivi minimal de 6 mois chez 113 patientes [Paper presentation]. 27ème congrès annuel de la Société Internationale Francophone d’Urodynamique et de Pelvi-Périnéologie, Bucarest, Romania.

Waltregny, D., North, B., Van Mellaert, F., de Leval, J., Verdin, E., & Castronovo, V. (2004). Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class IHDAC profiles between epithelial and stromal cells. European Journal of Histochemistry, 48 (3, Jul-Sep), 273-290.

Waltregny, D., Reul, O., Bonnet, P., & de Leval, J. (2004). Inside-out transobturator vaginal tape (TVT-O): Short-term results of a prospective study. International Urogynecology Journal.

Waltregny, D., Reul, O., Bonnet, P., & De Leval, J. (2004). Inside-out transobturator vaginal tape (TVT-O): Short-term results of a prospective study. Neurourology and Urodynamics, 23 (5-6), 428-429.

Wedel, T., van Eys, G., Waltregny, D., & Vanderwinden, J.-M. (2004). Novel markers reveal focal abnormalities of smooth muscles in human gastrointestinal motility disorders [Paper presentation]. 12th European Symposium on Neurogastroenterology and Motility (meeting of the European Society for Neurogastroenterology and Motiliy), Cambridge, United Kingdom.

Bonnet, P., Waltregny, D., & de Leval, J. (19 November 2003). La voie transobturatrice de dedans en dehors : considérations anatomiques [Poster presentation]. 97ème Congrès de l'Association Française d'Urologie AFU, Paris, France.

Chaplet, M., de Leval, L., Waltregny, D., Detry, C., Fornaciari, G., Bevilacqua, G., Fisher, L., Castronovo, V., & Bellahcene, A. (August 2003). Dentin matrix protein 1 is expressed in human lung cancer. Journal of Bone and Mineral Research, 18 (8), 1506-1512. doi:10.1359/jbmr.2003.18.8.1506

Detry, C., Waltregny, D., Quatresooz, P., Chaplet, M., Kedzia, W., Castronovo, V., Delvenne, P., & Bellahcene, A. (July 2003). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix. Calcified Tissue International, 73 (1), 9-14. doi:10.1007/s00223-002-2108-0

Garraway, L., Lin, D., Signoretti, S., Waltregny, D., Dilks, J., Bhattacharya, N., & Loda, M. (15 May 2003). Intermediate basal cells of the prostate: In vitro and in vivo characterization. Prostate, 55 (3), 206-218. doi:10.1002/pros.10244

Bouffioux, L., Willems, E., & Waltregny, D. (April 2003). Peut-on prevenir le developpement du cancer prostatique? Revue Médicale de Liège, 58 (4), 240-6.

Bonnet, P., Waltregny, D., & de Leval, J. (2003). La voie transobturatrice de dedans en dehors: Considérations anatomiques. Progrès en Urologie, 13(5) (Suppl.), 22.

Waltregny, D., Glénisson, W., Tran, S. L., Jackers, P., North, B., Weidle, U., Verdin, E., & Castronovo, V. (2003). Screening of histone deacetylase (HDAC) expression profiles in prostate cancer tissues leads to the identification of HDAC8 as a novel marker of smooth muscle differentiation [Paper presentation]. 6th annual meeting of ‘Innovators in Urology’, Amsterdam, Netherlands.

Andrianne, R., Limet, R., Waltregny, D., & de Leval, J. (December 2002). Hematurie causee par un "nutcracker syndrome" ou "syndrome du casse-noisettes": confirmation peroperatoire de sa realite. Progrès en Urologie, 12 (6), 1323-6.

De Leval, J., Boca, P., Yousef, E., Nicolas, H., Jeukenne, M., Seidel, L., Bouffioux, C., Coppens, L., Bonnet, P., Andrianne, R., & Waltregny, D. (December 2002). Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial. Clinical Prostate Cancer, 1 (3), 163-71. doi:10.3816/CGC.2002.n.018

Leduc, F., Ben Younes, A., Andrianne, R., Bonnet, P., Coppens, L., Waltregny, D., Fillet, M., Reul, O., & de Leval, J. (September 2002). Efficacy of upper urinary tract stones treatment by ESWL under local anesthesia, with the use of the Dornier Compact alpha Lithotriptor [Poster presentation]. Société Internationale d'Urologie SIU, Montréal, Canada.

Waltregny, D., Alami, Y., Clausse, N., de Leval, J., & Castronovo, V. (February 2002). Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate, 50 (3), 162-169. doi:10.1002/pros.10045

Castronovo, V., Waltregny, D., Fisher, L., & Bellahcene, A. (2002). The role of bone sialoprotein and other members of the SIBLING family in bone metastases formation. In 3rd International Conference on Osteopontin and SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) Proteins (pp. 195-197). The Scientific World eBook. doi:10.1100/tsw.2002.323

de Leval, J., & Waltregny, D. (2002). Les risques d’incontinence après prostatectomie radicale dépendent-ils du bilan lésionnel ? In R. Opsomer (Ed.), La prostatectomie radicale : Facteurs prédictifs d’incontinence et d’impuissance, Rapport du XXVème Congrès de la Société Internationale Francophone d’Urodynamique.

Detry, C., Castronovo, V., Waltregny, D., Delvenne, P., & Bellahcene, A. (2002). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium.

Leduc, F., Ben Younes, A., Reul, O., FILLET, M., Waltregny, D., Andrianne, R., & de Leval, J. (2002). Efficacy of upper urinary tract stones treatment by ESWL under local anesthesia, with the use of the Dornier compact alpha lithotriptor [Poster presentation]. Annual meeting of the Société Internationale d’Urologie, Stockholm, Sweden.

Lindeman, N., Waltregny, D., Signoretti, S., & Loda, M. (2002). Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection. Diagnostic Molecular Pathology, 11 (4), 187-92. doi:10.1097/00019606-200212000-00001

Waltregny, D., Boca, P., Nicolas, H., Youssef, E., Jeukenne, M., Bouffioux, C., Coppens, L., Andrianne, R., Bonnet, P., & de Leval, J. (2002). Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naïve prostate cancer. Results of a randomiszed prospective multicenter clinical trial. Journal of Urology, 167, 175 (A701.

Waltregny, D., & de Leval, J. (2002). Les risques d’incontinence après prostatectomie radicale dépendent-ils du bilan lésionnel ?

Reul, O., Waltregny, D., Boverie, J., De Leval, J., & Andrianne, R. (December 2001). Pyelonephrite xanthogranulomateuse pseudotumorale: diagnostic par la biopsie percutanee et succes du traitement conservateur. Progrès en Urologie, 11 (6), 1274-6.

Waltregny, D. (2001). Etude du rôle et de la régulation de l’inhibiteur du cycle cellulaire p27KIP1 dans la prostate normale et néoplasique [Specialised master, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/36200

Waltregny, D. (June 2001). Etude du rôle et de la régulation de l’inhibiteur du cycle cellulaire p27KIP1 dans la prostate normale et néoplasique [Paper presentation]. Réunion annuelle de la Société Belge d'Urologie, Louvain-la-Neuve, Belgium.

de Leval, J., Boca, P., Youssef, E., Nicolas, H., Jeukenne, M., Andrianne, R., Bouffioux, C., Bonnet, P., & Waltregny, D. (2001). Intermittent versus continuous total androgen blockade in the treatment of patients with hormone-naïve advanced prostate cancer: Results of a phase III randomized prospective multicenter clinical trial [Paper presentation]. Special Conference of the American Association for Cancer Research: New Discoveries in Prostate Cancer Biology and Treatment, Naples, FL, United States.

De Pinieux, G., Flam, T., Zerbib, M., Taupin, P., Bellahcene, A., Waltregny, D., Vieillefond, A., & Poupon, M.-F. (2001). Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: a clinicopathological and immunohistochemical study of 43 cases. Journal of Urology, 166 (5), 1924-30. doi:10.1016/S0022-5347(05)65722-9

Lindeman, N., Waltregny, D., Signoretti, S., & Loda, M. (2001). Rapid immunostaining of frozen sections: a tool for laser capture microdissection and quantitative RT-PCR. Laboratory Investigation, 81, 37.

Locigno, R., Henno, A., Waltregny, D., & Castronovo, V. (2001). Sodium butyrate and trichostatin-a induce apoptosis in human breast cancer cells but not in normal human mammary epithelial cells. Proceedings of the American Association for Cancer Research, 42, 635.

Locigno, R., Waltregny, D., Verheyen, V., Henno, A., & Castronovo, V. (January 2001). Sodium butyrate and trichostatin A induce growth arrest and apoptosis in breast cancer cells while normal breast epithelial cells are unaffected [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium.

Signoretti, S., Monti, F., Isaac, B., Waltregny, D., Dilks, J., Gelman, R., Pagano, M., & Loda, M. (2001). The p27 ubiquitin ligase skp2 is overexpressed in breast cancer. Laboratory Investigation, 81, 233.

van den Brule, F., Waltregny, D., & Castronovo, V. (January 2001). Increased Expression of Galectin-1 in Carcinoma-Associated Stroma Predicts Poor Outcome in Prostate Carcinoma Patients. Journal of Pathology, 193 (1), 80-7. doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH730>3.0.CO;2-2

Waltregny, D., De Leval, L., Coppens, L., Youssef, E., De Leval, J., & Castronovo, V. (2001). Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy. European Urology, 40 (5), 495-503. doi:10.1159/000049825

Waltregny, D., Leav, I., Signoretti, S., Soung, P., Lin, D., Merk, F., Adams, J. Y., Bhattacharya, N., Cirenei, N., & Loda, M. (2001). Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Molecular Endocrinology, 15 (5), 765-82. doi:10.1210/mend.15.5.0640

van den Brule, F., Waltregny, D., Liu, F. T., & Castronovo, V. (20 July 2000). Alteration of the Cytoplasmic/Nuclear Expression Pattern of Galectin-3 Correlates with Prostate Carcinoma Progression. International Journal of Cancer, 89 (4), 361-7. doi:10.1002/1097-0215(20000720)89:4<361::AID-IJC8>3.3.CO;2-L

Waltregny, D., Bellahcene, A., de Leval, X., Florkin, B., Weidle, U., & Castronovo, V. (May 2000). Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers. Journal of Bone and Mineral Research, 15 (5), 834-43. doi:10.1359/jbmr.2000.15.5.834

Signoretti, S., Waltregny, D., Dilks, J., Isaac, B., Lin, D., Garraway, L., Yang, A., Montironi, R., McKeon, F., & Loda, M. (2000). p63 is a prostate basal cell marker and is required for prostate development. American Journal of Pathology, 157 (6), 1769-75. doi:10.1016/S0002-9440(10)64814-6

van den Brule, F., Waltregny, D., & Castronovo, V. (2000). Increased expression of Galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. Proceedings of the American Association for Cancer Research, 41, 386.

Waltregny, D., de Leval, L., Coppens, L., de Leval, J., & Castronovo, V. (2000). Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy [Paper presentation]. 15th annual meeting of the European Association of Urology, Bruxelles, Belgium.

Bonnet, P., Coppens, L., Andrianne, R., Waltregny, D., Keppenne, V., Leduc, F., Fillet, M., Ghammad, S., & de Leval, J. (November 1999). Chirurgie, radiotherapie ou hormonotherapie dans le traitement du cancer de la prostate. Revue Médicale de Liège, 54 (11), 875-85.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis. In G. G. Skouteris & G. L. Nicolson (Eds.), Intermolecular Cross-Talk in Tumor Metastasis. Amsterdam, Netherlands: IOS Press.

Demarche, M., Waltregny, D., Van Damme, H., & Limet, R. (April 1999). Femoral Anastomotic Aneurysms: Pathogenic Factors, Clinical Presentations and Treatment. A Study of 142 Cases. Cardiovascular Surgery, 7 (3), 315-22. doi:10.1016/S0967-2109(98)00161-6

Waltregny, D. (1999). Contribution to the prognostic evaluation of prostate cancer lesions: Usefulness of the detection of the 67kDa laminin receptor and bone sialoprotein in clinically confined prostate cancer [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/36188

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in the process of bone metastases development. Amsterdam, Netherlands: IOS Press.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis [Paper presentation]. 26th European Symposium on Calcified Tissues, Maastricht, Netherlands.

Clausse, N., van den Brule, F., Waltregny, D., Garnier, F., & Castronovo, V. (1999). Galectin-1 Expression in Prostate Tumor-Associated Capillary Endothelial Cells Is Increased by Prostate Carcinoma Cells and Modulates Heterotypic Cell-Cell Adhesion. Angiogenesis, 3 (4), 317-25. doi:10.1023/A:1026584523789

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1999). Increased expression of bone sialoprotein in skeletal metastases compared with non skeletal metastases from human breast and prostate cancers [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Anvers, Belgium.

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L. W., Young, M., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (01 July 1998). Prognostic Value of Bone Sialoprotein Expression in Clinically Localized Human Prostate Cancer. Journal of the National Cancer Institute, 90 (13), 1000-8. doi:10.1093/jnci/90.13.1000

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, de Leval, J., & Castronovo, V. (23 January 1998). Expression of bone sialoprotein in human prostate is associated with progression [Paper presentation]. 5th Euregional Oncology meeting, Maastricht, Netherlands.

Bellahcene, A., Albert, V., Nyabi, O., Cheung, N. K. V., Kramer, K., Waltregny, D., Fisher, L., & Castronovo, V. (1998). Bone sialoprotein is expressed in both human neuroblastoma tissues and cell lines. Proceedings of the American Association for Cancer Research, 39, 209.

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1998). Detection of bone sialoprotein in primary and metastatic lesions of human breast and prostate carcinomas, the two major osteotropic cancers. Revue du Rhumatisme, 7-9, 527.

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Proceedings of the American Association for Cancer Research, 39, 322.

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (January 1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Acta Clinica Belgica, 53 (3), 221-240.

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (17 January 1997). Independent value of the 67-kilodalton laminin receptor in human prostate cancer [Paper presentation]. 4th Euregional Oncology meeting, Maastricht, Netherlands.

Dehan, P., Waltregny, D., Beschin, A., Noël, A., Castronovo, V., Tryggvason, K., De Leval, J., & Foidart, J.-M. (1997). Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. American Journal of Pathology, 151 (4), 1097-104.

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Overexpression of the 67-kD laminin receptor correlates with tumor progression in human prostate cancer. Proceedings of the American Association for Cancer Research, 38, 429.

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Independent value of the 67-kilodalton laminin receptor in human prostate cancer. Acta Clinica Belgica, 52 (2), 93.

Waltregny, D., de Leval, L., Menard, S., de Leval, J., & Castronovo, V. (1997). Independent prognostic value of the 67-kd laminin receptor in human prostate cancer. Journal of the National Cancer Institute, 89 (16), 1224-7. doi:10.1093/jnci/89.16.1224

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Independent prognostic value of the 67-kD laminin receptor in human prostate cancer. British Journal of Urology, 80 (Suppl. 2), 231.

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (March 1996). Overexpression of the 67-kDa laminin receptor correlates with tumor progression in human prostate cancer. Clinical and Experimental Metastasis, 14 (Suppl. 1), 1996.

Waltregny, D., & Castronovo, V. (1996). Recent advances in prostate cancer metastasis. Tumori Journal, 82 (3, May-Jun), 193-204.

Waltregny, D., & de Leval, J. (May 1995). Exploration du testicule cryptorchide non palpe. Acta Urologica Belgica, 63 (2), 69-76.

de Leval, L., Waltregny, D., Greimers, R., & Boniver, J. (April 1994). Flow cytometry in prostate cancer: Histological and clinical correlation. Acta Urologica Belgica, 62 (1), 37-43.

de Leval, L., Waltregny, D., Greimers, R., & Boniver, J. (January 1994). Cytofluorometric analysis of prostate cancer specimens: Histological and clinical correlations. Acta Urologica Belgica, 62, 37-43.

REGINSTER, M.-A., Mazy, V., Waltregny, D., LACREMANS, D., Focan, C., Jardon-Jeghers, C., & Boniver, J. (April 1993). Angiosarcome hépatique chez une patiente ayant présenté une hépatite autoimmune. Revue Médicale de Liège, 48 (4), 220-3.